.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Glenna's category mix compressed to two lines with Flower at 58.52% share and Concentrates at 41.48% share, but both contracted sharply: Flower was down 71.40% year over year and 51.91% month over month, while Concentrates fell 89.26% year over year and 66.83% month over month. The brand’s average price was down 24.51% year over year to $22.12, with category price points diverging at $19.16 for Flower and $28.26 for Concentrates; combined with a brand-level sales decline of 86.96% year over year, this mix implies a shift toward lower-priced units without offsetting volume. The net pattern is that Concentrates is shrinking faster than Flower, pulling the portfolio toward lower price realization and away from Glenna’s historical higher-value center, which will pressure margin and visibility if sustained.
The steeper contraction in Concentrates (down 66.83% month over month versus Flower down 51.91% month over month) alongside a 24.51% year-over-year price reduction signals that Glenna's is ceding premium space while relying more on Flower to carry volume at lower price points. With no observable rank for Concentrates in New York, and the brand’s 24-month sales down 76.00%, the portfolio tilt implies weakened shelf authority in higher-intent missions and a need to recalibrate pack sizes or potency tiers to rebuild price-to-value in Concentrates while protecting Flower velocity; otherwise, continued price compression and mix drift will entrench a lower-margin positioning.
Competitive Landscape
Glenna's sits at rank #43 in NY Concentrates in July 2026, a 28-position decline from #15 year over year, but a 27-rank climb from #70 three months ago, indicating volatility across recent periods. The brand is far from its peak at #6 in January 2025, a 37-spot gap from today, while category leaders tightened their positions: Mfny (Marijuana Farms New York) held #1 with 47.5% YoY sales growth and Jetpacks advanced from #3 to #2 with 56.4% YoY growth, outpacing Glenna's rank movement in both absolute position and trajectory. Meanwhile, UMAMII surged from #27 to #3 (+24 ranks) alongside 1,758.2% YoY sales growth, and Nyce moved from #9 to #5 (+4 ranks), reinforcing a competitive squeeze near the top; this combination of a 28-rank YoY drop and a recent 27-rank rebound implies Glenna's is in recovery mode but must convert short-term gains into sustained share capture to prevent further drift from top-tier positions.
Notable Products
RS-11 (3.5g) posted the steepest decline at -90.38% and slid to rank 3 in July 2026, while Black Runtz Cured Resin Sugar (1g) fell -91.43% to rank 5, indicating a rapid pullback in two previously scaled SKUs. In contrast, Mendo Breath (3.5g) surged +66.43% to rank 1 with $8,513, and RS-11 Cured Resin (1g) dropped -34.09% to rank 2, so leadership consolidated around one Flower SKU even as a key Concentrates SKU weakened. With three of the top five belonging to Concentrates and two of them contracting by more than -30%, Glenna's is leaning on a single Flower winner to offset a Concentrates downswing. The mix implies Glenna's will need to stabilize Concentrates while expanding Flower depth to avoid over-reliance on Mendo Breath for headline growth.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
